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Reproducibility of Echocardiographic
MeasurementsKarina V. Bunting, BSc, MSc, Richard P. Steeds, MBBS, MA, MD, FESC, Luke T. Slater, BSc,
Jennifer K. Rogers, BSc, PhD, CStat, AFHEA, Georgios V. Gkoutos, PhD, DIC, and
Dipak Kotecha, MBChB, PhD, MSc, FESC, FHEA, Birmingham, United Kingdom
Echocardiography plays an essential role in the diagnosis and assessment of cardiovascular disease. Mea-
surements derived from echocardiography are also used to determine the severity of disease, its progression
over time, and to aid in the choice of optimal therapy. It is therefore clinically important that echocardiographic
measurements be reproducible, repeatable, and reliable. There are a variety of statistical tests available to
assess these parameters, and in this article the authors summarize those available for use by echocardiog-
raphers to improve their clinical practice. Correlation coefficients, linear regression, Bland-Altman plots,
and the coefficient of variation are explored, along with their limitations. The authors also provide an online
tool for the easy calculation of these statistics in the clinical environment (www.birmingham.ac.uk/echo).
Quantifying and enhancing the reproducibility of echocardiography has important potential to improve the
value of echocardiography as the basis for good clinical decision-making. (J Am Soc Echocardiogr
2019;32:1505-15.)
Keywords: Echocardiography, Reproducibility, Repeatability, ReliabilityEchocardiography is a key cardiac investigation that has contributed
to improvements in the diagnosis and management of cardiovascular
disease.1,2 The use of echocardiography continues to grow, not only
in number but also in the types of measurements, from M-mode
to two-dimensional imaging, Doppler echocardiography, three-
dimensional imaging, and speckle-tracking. However, inpatient hospi-
tal data suggest that echocardiography continues to be underused in
critical cardiovascular conditions, and it is an operator-dependent
technique that is prone to variable reproducibility.3 Defining a repro-
ducible measurement from echocardiography is challenging because
of intrinsic biologic variation and the difference in measurement and
interpretation between operators.
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itable that there will be some degree of error in clinical measurements,
and the acceptable amount will depend on particular circumstances.5-
7 The correct statistical tests to determine these forms of
reproducibility are often poorly considered, with the potential to
mislead and confound clinical decision-making.7
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Table 1 Terms of reference
Term E
Reproducibility Variation of th
made on a
conditions o
Repeatability Variation in re
made on th
identical co
Reliability Magnitude of
repeated m
2D, Two-dimensional; 3D, three-dim
Abbreviations
ICC = Intraclass correlation
coefficient
LVEF = Left ventricular
ejection fraction
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December 2019review the literature on
reproducibility, repeatability,
and reliability in the practical
context of echocardiography. In
Table 1, we provide a summary
of statistical tests to assess repro-
ducibility, repeatability, and reli-ability. Table 2 highlights the application of these tests, giving
examples specific to echocardiography. Our aim is to provide echo-
cardiographers and clinicians with the tools to appraise their own
measurements, reduce inconsistencies within and between operators,
and improve the reliability of echocardiography in clinical practice. To
enable assessment in routine clinical care, we provide an online calcu-
lator for key statistical tests and graphs, allowing users to input mea-
surements and easily assess their own reproducibility: www.
birmingham.ac.uk/echo.REPRODUCIBILITY
Reproducibility assesses the degree of variation in a measurement
when conditions are changed. In echocardiography, this could bexplanation
E
applica
e same measurement
subject under changing
r different operators
Comparing
valve pe
patient b
echocar
Comparing
regurgit
echocar
mild, mo
Comparing
measure
made b
and 3D
Assessing
ventricu
measure
the echo
peat measurements
e same subject under
nditions
Assessing
consecu
by the s
for tissu
error between
easurements
Assess wi
variation
effective
between
ensional.used to assess the variability in different operators, between different
echocardiography sessions, or across separate patients with the same
condition. When assessing reproducibility, statistical tests can assess
correlation, bias, and agreement; together these are used to form a
conclusion as to whether a study is reproducible (see Table 1 for a
summary of terms). Correlation is defined as how well one variable
can be used to predict the other, bias is whether there is a systematic
difference from the expected value (either under- or overestimation),
and agreement is defined as how close two measurements are from
one another when on the same scale.5,21
We explore these three aspects in detail below, along with
their limitations, using the example of Simpson’s biplane left ven-
tricular ejection fraction (LVEF) assessed by two operators
(Figure 1).Association
Association assesses the relationship between groups of data,
with higher values (either positive or negative) suggesting a
closer association. The choice of association statistic depends
on the type of data available, and below we discuss four main
options.xamples of practical
tion in echocardiography Most valuable statistical tests
measurements of aortic
ak velocity on the same
y two different
diographers.
Correlation coefficients for
association: Pearson or Spearman
correlation (r) and linear regression
(percentage of variation
explained = r2).
the grade of mitral
ation by two
diographers as none,
derate, or severe.
Measure of the agreement between
two operators: Cohen’s k (or
weighted k for degree of
disagreement). k = (total number of
agreements  total agreements
due to chance)/(total
observations  total agreements
due to chance).
the difference in
ment of ejection fraction
y 2D Simpson’s biplane
volumes.
Agreement: Bland-Altman limits of
agreement = bias (average
difference between
measurements) 6 1.96  SD.
the correlation of left
lar outflow tract diameter
d by multiple operators in
cardiography department.
Intraclass correlation coefficient
(requires complex computation).
the difference in
tive beats
ame operator
e Doppler E/e0 ratio.
Repeatability coefficient = within-
subject SD  O2  1.96.
thin a department the
in mitral regurgitation
regurgitant orifice area
operators.
Minimal detectable
change = 1.96  O2  SEM.
Coefficient of variation = SD/
mean  100.
Percentage change = (second
measurement  first measurement)/
average  100.
HIGHLIGHTS
 Good reproducibility, repeatability, and reliability are essential
for echo studies.
 Straightforward statistical evaluation can improve echocardi-
ography practice.
 A free online tool is available at www.birmingham.ac.uk/echo.
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Bunting et al 1507Correlation Coefficient. The correlation coefficient (r) simply
measures the linear relationship between two variables. The most
commonly used methods are the Pearson correlation coefficient
(for normally distributed variables) and the Spearman correlation co-
efficient (for skewed variables, using a ranking of the measurements).
An r value of 0 implies no correlation between the variables at all. If
there were a perfect correlation between two variables, the r value
would equal 1 (or 1 if perfectly and inversely correlated).22,23 In
reality, no clinical variables could attain this level of correlation, but
an r value above 0.8 shows a very strong correlation and between
0.6 and 0.8 a strong correlation.24 It should be emphasized that cor-
relation is not a good measure of agreement (discussed later) and will
depend on the range of the measurement in question.25 Statistical
tests can be used to determine if these correlations are likely due to
chance; P values in this context do not refer to the strength of corre-
lation but instead indicate whether we have confidence in the corre-
lation coefficient. Figures 1A, 1B, and 1C demonstrate strong or very
strong correlations between the two operators for LVEF, in contrast to
Figure 1D, in which correlation is relatively weak. These methods are
best used for paired parameters, such as intraobserver variability (the
same operator taking an echocardiographic measure twice on the
same subject and assessing the variation) or interobserver variability
(two operators taking the same measure on the same subject and as-
sessing their variation).
Linear Regression. Regression analysis describes how well one
variable can be used to predict the value of another, or the strength
of their relationship. With enough data points, a ‘‘line of best fit’’
can be created on the basis of the regression equation: variable
1 = constant value + coefficient variable 2. Given the two variables,
the regression model provides the constant value and the coefficient
by trying to minimize the difference between the true observed value
and the value predicted from the model (also known as the residual).
This method requires data that are normally distributed (not skewed)
and can be affected by outlying values. It only measures to what
extent two variables are linearly related (in many cases, the associa-
tion can be more complex).9,26 The value of linear regression is
limited, but it can be useful to visualize the association of paired
data before other statistical tests. As with any statistical
measurement, there is some variability. The 95% CI gives us an
idea of the bounds of uncertainty around the calculated estimate.
Figure 1A shows a very close relationship between the values from
the two operators, with a regression coefficient of 0.90. This means
that for every 1.0% increase in LVEF ratings in the future by operator
1, we would expect that the corresponding average LVEF measure-
ment of operator 2 would increase by 0.9%. The CI suggests that if
repeated samples are taken, there is a 95% chance that the true
regression coefficient will lie in the interval between 0.45 and 1.34.
Conversely, Figure 1D shows a very variable relationship, with a
regression coefficient of 0.15 and a broad CI (from 0.28 to 0.60).This includes the value of 0, meaning that there may be no association
between the operators at all.
Intraclass Correlation Coefficient. The intraclass correlation co-
efficient (ICC) is often used to determine the reproducibility and reli-
ability of numeric measurements organized into groups beyond a
simple pairing, for example, different operators measuring the same
variable in different patients. The formulas for ICC are complex,
but essentially they pool data and compare within and across opera-
tors on the basis of an analysis of variance. This divides the total vari-
ability into actual difference and error, and the ICC is an average of all
the correlations on the basis of all the possible pairs of data.27 In
essence, the ICC is giving us confidence about how closely the values
are alike in different groups of data. The ICC can be used to assess
variability within a single operator (intraobserver), between different
operators (interobserver), or across different time points. It possesses
the advantage of being able to comparemore than two groups of vari-
ables (more than two operators) and may be superior to Pearson and
Spearman correlation coefficients because it considers systematic dif-
ferences.28 The disadvantage of ICC is that it has limited value for
comparing reproducibility of results in different populations.
Because the ICC is a dimensionless value, the outcome will vary ac-
cording to the dependent variables in the population sampled; data
with a wide range of values will generate a high ICC value, whereas
datawith a narrow range of values will result in a low ICC.22,29,30 ICC
is unhelpful if the indices show poor agreement, as there is no
indication as to the source of the error. Although there is no strict
ICC value that marks the cutoff for appropriate correlation,7,23
values between 0.75 and 1.00 suggest excellent correlation,
between 0.60 and 0.74 good correlation, and <0.4 poor
correlation.31 Interpretation of the ICC is demonstrated when
comparing Figures 1A and 1B. Whereas the standard correlation co-
efficients are similar (0.82 and 0.70), the ICCs are considerably
different (0.90 and 0.48) because of greater variance between the
two operators in example B. However both are statistically significant,
in contrast to Figure 1D.
With the online calculator, this method can be more widely used,
as it allows the assessment of reproducibility in more than two groups.
For example, it can be used to assess interobserver variability across all
members of the echocardiography department. For more complex
scenarios, or for readers planning to calculate the ICC, we would
recommend review of guidance on the correct selection and report-
ing of the ICC.32Bias
Bias indicates to what extent there is a true difference in two data
points that has not resulted from chance. These statistical tests can
help determine if there are significant differences in paired data,
for example, two recordings of left ventricular outflow tract diam-
eter. A small probability (often P < .05, which is less than one in
20) suggests that there is evidence for a difference in the two mea-
surements (i.e., we reject the null hypothesis, which is that there is no
difference in values).33 It is important to note that the strength of sta-
tistical significance is not related to the extent of bias but rather to
whether there is confidence in the rejection of a chance effect.
Paired t tests are used for normally distributed data, and the
Wilcoxon test is used for skewed data. In our example, the bias
assessment is not significant for Figures 1A and 1D, whereas there
is a systematic bias in Figure 1B that is highly statistically significant
at P = .004 and gives evidence for a true difference between the
Table 2 Statistical methods useful in echocardiography
Statistical method Strengths of method Weakness of method Examples from published literature
Association
Correlation
coefficient
Options for normally distributed data
(Pearson) and skewed data
(Spearman).
Can only account for linear relationships.
Sensitive to outlying values.
n = 17 with heart failure or dilated
cardiomyopathy. Very strong
interoperator association between
LVEF and GLS: Pearson’s correlation
coefficient r = 0.89 for LVEF and
r = 0.97 for GLS.10
Linear regression The regression line can be used to
predict the value of one variable from
another.
Analysis of the difference between the
observed and predicted values
(residuals).
Can be used only if the data are normally
distributed.
Assumes the same degree of variance
across the whole variable.
Sensitive to outlying values.
n = 31 patients clinically indicated for
cardiac CT. Strong correlations seen
between different imaging modalities
when measuring volumes and LVEF.
For cardiac CT vs CMR, linear
regression r2 = 0.85; regression
equation y = 0.97x 1.3. For 3D TTE vs
CMR, r2 = 0.93; regression equation
y = 0.87x + 6.3.11
Intraclass correlation coefficient Assesses how closely variables are
related to each other.
Best for a large number of observations.
Accounts for a change in the mean over
time.
Independent of the scale of
measurement and size of error.
As with other measures above, shows
correlation, not causation.
No fixed clinical interpretation for level of
agreement.
Cannot be used to compare reliability of
measurements among different studies.
Affected by the size of the range of data.
n = 183 patients with hypertension,
comparing twomeasurements 45 days
apart. Excellent correlation between
first and second study: ICCs of 0.90 for
indexed LV mass and 0.85 for septal
diameter.12
Bias
t test Provides a P value for paired data sets. For normally distributed data only. n = 88 patients before chemotherapy.
Differences in intra- and interobserver
variability of LVEF and volumes were
assessed using a t test, with P < .001
considered to indicate statistical
significance. Noncontrast 3D
echocardiography had significantly
lower variability than 2D Simpson’s
method, 2D triplane, or studies using
contrast.13
Wilcoxon signed
rank/Mann-Whitney U test
Can be used for skewed data. Uses ranking, so assessment of raw data
is needed to interpret the P value.
n = 284 children with evaluation of
MAPSE using B-mode and M-mode
imaging. M-mode MAPSE had
significantly lower variability than B-
mode lateral MAPSE for both
interobserver (P < .001) and
intraobserver (P < .001) observer
variability (using Wilcoxon signed rank
test).14
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Agreement
Bland-Altman plot Demonstrates degree of agreement and
depicts outliers.
Demonstrates systematic bias.
Unable to detect proportional bias.
Assumes normal distribution.
Numeric data only.
A clinical decision needs to be made as
to whether there is good agreement on
the basis of the width of confidence
limits.
n = 50 trastuzumab patients comparing
two scans a minimum of 14 days apart
by the same operator, showing better
agreement for GLS than Simpson’s
biplane LVEF. For GLS, bias = 0.1
between the two time periods; limits of
agreement = 1.8 to 1.7. For LVEF,
bias = 0.5; limits of agreement = 11.2
to 12.1.15
Cohen’s k Measures agreement and takes into
account the amount of agreement
which is there by chance.
Dependent on the prevalence of a
condition.
Doesn’t account for degree of
disagreement.
n = 146 enrolled in the Multi-Ethnic Study
of Atherosclerosis with
echocardiography and CMR on the
same day. For classification of
hypertrophy (normalized for body
surface area), there was weak
agreement between modalities, albeit
statistically significant (Cohen’s
k = 0.37, P < .001).16
Weighted k Weights the degree of agreement and
disagreement between data sets.
Requires a predefined table of weights. n = 80 with clinical aortic stenosis
undergoing cardiac CT and TEE. Weak
agreement between modalities for
grading aortic valve calcification:
weighted k = 0.34.17
Repeatability
RC Uses the units of the variable. Assumes normally distributed data.
Unsuitable if the extent of agreement
depends on the value of the
measurement.
n = 67 pregnant women with
measurement of transabdominal
Doppler ultrasound of the ductus
venosus at 10–14 weeks of gestation.
Intraobserver repeatability was better
for pulsatility index for veins
(RC = 1.27) compared with end-
diastolic velocity (RC = 2.03).18
Reliability
MDC To assess reliability of measurements.
Simple method to detect change.
Suited more for short intervals between
repeated measurements.
n = 56 patients referred for
echocardiography before beginning
trastuzumab treatment. Lowest intra-
and interobserver variability for
assessing LVEF shownwith 3Dwithout
contrast (MDC = 0.048% and 0.075%)
vs other echocardiographic methods
with and without contrast.13
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December 2019two operators. If the data points are clustered equally around the
line of equality, this suggests that there is no systematic bias.
Notably, Figure 1C shows a proportional bias, and so a t test is likely
to be inaccurate in this case. Proportional bias occurs when the dif-
ference between measurements is dependent on the value of the
measurement taken.34Agreement
Agreement defines the degree of consensus between different mea-
surements, and different statistical comparisons are available accord-
ing to whether the data are continuous or categorical.
Bland-Altman Plot. The Bland-Altman plot is widely used to visu-
alize the difference in two continuous measurements from the same
individual, graphed according to the average value of the two mea-
sures. In terms of echocardiography, this is highly valuable to assess
measurements taken on the same patient by two different echocardi-
ographers. This method can also be used for assessing two measure-
ments made by the same operator or two measurements using
different techniques or in different environments.
Creating the Bland-Altman plot is straightforward and requires (1)
plotting the difference in the pair of measurements against their
mean, (2) calculating and plotting the bias (the mean of the differ-
ences), and (3) calculating and plotting the upper and lower limits
of agreement (bias 6 1.96  SD of difference). The limits of agree-
ment indicate where the true mean (and future measurements) are
likely to lie, and interpretation will depend on the clinical magnitude
of the limits.23,35 If values are consistently outside the confidence
limits, it may indicate a lack of agreement or a true biologic
difference that is not due just to sampling error.5,35
Figure 2 shows the examples from Figure 1 constructed into Bland-
Altman plots. Figure 2A shows a small degree of bias (0.67) and
narrow limits of agreement (8.3 to 6.9), whereas Figure 2B shows
a systematically higher LVEF from operator 2 for each measurement.
In Figure 2C, there is evidence of a proportional error, with increasing
difference between measurements at both extremes of LVEF.
Figure 2D shows very wide limits of agreement (35.6 to 36.8)
that are likely to be highly clinically relevant.
Kappa Statistics. Cohen’s k is used to assess the agreement be-
tween categorical data (measurements with different levels, such as
the severity of valve disease or categories of left ventricular dysfunc-
tion). The result ranges from 0 (no agreement) to 1 (perfect agree-
ment), with values < 0.6 indicating weak agreement and >0.8
strong agreement. Cohen’s k takes into account disagreement be-
tween the two operators and also agreement by chance. A modified
approach, the weighted k, can be used to determine the degree of
disagreement using a predefined table of weights.7 Figure 3A demon-
strates strong agreement between the two observers (k = 0.89) as for
each case they made a similar grading for the severity of mitral regur-
gitation in the same patients. In contrast, Figure 3B shows almost no
agreement between the two observers across the severity of mitral
regurgitation (k = 0.05). Figure 3C shows that there is good agree-
ment between the two observers for cases with ‘‘severe’’ disease,
but overall the agreement is weak because of a lack of consistent re-
sults with other categories of mitral regurgitation (k=0.27). Figure 2D
shows overall moderate agreement across all cases (k = 0.65) despite
there being 100% agreement for patients with nomitral regurgitation.
Note that Cohen’s k is not the only statistic that can be used to assess
agreement for categorical data, and other measures are available to
address some of its assumptions and shortcomings. These include
020
40
60
80
100
0 20 40 60 80 100
O
pe
ra
to
r 2
:  
LV
EF
 (%
) 
Operator 1:  LVEF (%) 
0
20
40
60
80
100
0 20 40 60 80 100
O
pe
ra
to
r 2
:  
LV
EF
 (%
) 
Operator 1:  LVEF (%) 
0
20
40
60
80
100
0 20 40 60 80 100
O
pe
ra
to
r 2
:  
LV
EF
 (%
) 
Operator 1:  LVEF (%) 
0
20
40
60
80
100
0 20 40 60 80 100
O
pe
ra
to
r 2
:  
LV
EF
 (%
) 
Operator 1:  LVEF (%) 
Correlation
Regression 
gradient
(95% CI)  
0.64  
(0.18 to 
1.09)
Intraclass 
correlation 
0.48 
(P=.004) 
Bias
Mean bias 23.75  
(SD 15.0)  
Paired t-test P=.004 
Correlation
Regression 
gradient
(95% CI)  
0.46   
(0.26 to
0.67)
Intraclass 
correlation 
0.85 
(P=.003) 
Bias
Mean bias -1.25 
(SD 20.6)
Paired t-test P=.44 
Correlation
Regression 
gradient
(95% CI)  
0.15  
(-0.28 to
0.60)
Intraclass 
correlation 
0.38  
(P=.23)  
Bias
Mean bias 0.58  
(SD 19.5)  
Paired t-test P=.28 
Correlation
Regression 
gradient
(95% CI)  
0.90   
(0.45 to
1.34)
Intraclass 
correlation 
0.90 
(P≤.001)
Bias
Mean bias -0.67  
(SD 12.9 ) 
Paired t-test P=.86 
Example A Example B
Example C Example D
Figure 1 Reproducibility assessment between two operators. Four examples of scatterplots showing interoperator reproducibility
and related statistical tests for LVEF. Black dotted line is the line of equality, and red dashed line is the line of best fit (linear regression
line). (A) Very strong correlation with no evidence of bias. (B) Strong correlation but with significant bias, as operator 1 is consistently
measuring LVEF at a lower value than operator 2. (C) Very strong correlation, but the difference in the two operators changes accord-
ing to ejection fraction (proportional bias). (D)Weak correlation but no bias. Note that P values provide an assessment of statistical
significance (whether due to chance) but do not imply any strength of correlation.
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efficient, among others.36REPEATABILITY
Repeatability studies are used to ensure that minimal variation exists
when the measurement is retested on the same subject or group: the
smaller the variation, the more reliable the results. When carrying out
test-retest procedures, if the conditions in which themeasurement are
taken are kept exactly the same, then any variation detected can be
attributed to the accuracy of the measurement. The time interval be-
tween repetitions should be short enough to exclude any biological
change but long enough to prevent any interference from the preced-
ing test. The appropriate time interval will vary depending on the sit-
uation,23 but for echocardiography, repeating measurements on the
same day with an interval of at least a fewminutes would seem appro-
priate. For calculations that require multiple echocardiographic
measurements for calculation, such as aortic valve area, it is important
to obtain measurements under similar hemodynamic conditions.
Therefore, in the context of any cardiac arrhythmias, similar cardiac
cycle lengths should be selected for measurement.37 Variability of
results within a single patient can be assessed statistically by the
repeatability coefficient (using the SD of differences), the coefficient
of variation (discussed further below), or an ICC. The advantage of
the repeatability coefficient is that its value is in the same units
as the measurement, allowing easier interpretation to guide
decision-making.6,30Figure 4 shows an example for peak aortic valve velocity in four
patients undergoing 10 consecutive measurements by the same oper-
ator for possible aortic stenosis. Figure 4A demonstrates a repeat-
ability coefficient of 13 cm/sec, meaning that the variation in future
measurements for aortic valve peak velocity are small (by that echo-
cardiographer on that particular patient). Figure 4B shows propor-
tional bias for velocity to increase in value as the observer takes
more measurements, whereas Figure 4C displays clinically relevant
variation (perhaps due to a patient factor such as atrial fibrillation).
In Figure 4D we see major issues in repeatability (e.g., because of
equipment problems).RELIABILITY
To be a reliable measurement, the magnitude of the difference be-
tween repeated measurements should be within a clinically accept-
able limit. The test should be precise enough to give us confidence
that we can differentiate between normal or abnormal in a given pop-
ulation or between different patients or populations. The minimal
detectable change can be used to assess reliability when measure-
ments are repeated over a short time interval.38 It is expressed as a
percentage and represents the minimal change required to be sure
that the differences observed reflect a real change rather than mea-
surement error (with higher percentages suggesting a less reliable
method).39 The coefficient of variation is a common method to
compare reliability between tests. It is calculated as the ratio of SD
to mean, with a smaller percentage indicating a more precise
method.9,40 This would be useful in echocardiography for assessing
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Figure 2 Bland-Altman plots for agreement between two tests or operators. Bland-Altman plots showing assessment of agreement
for the four examples in Figure 1. (A) No bias between measurements or assessors and narrow limits of agreement. (B) Substantial
bias (observation 2 is systematically higher than observation 1) but with narrow limits of agreement. (C) Low levels of bias but broad
limits of agreement. (D) Low levels of bias with even broader limits of agreement.
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example, different measures of left atrial dilatation in the same
patients with hypertension or the reliability of averaging different
numbers of cardiac cycles in those with atrial fibrillation.
Interpretation of minimal detectable change and the coefficient of
variation is depicted in Figure 4.
Simple assessment of reliability can also be calculated, such as the
absolute or percentage change in twomeasurements. However, these
tests have limited statistical power to determine differences, are un-
able to account for inherent variation, and the results are highly
dependent on the value at baseline.41,42 Whatever method is used,
echocardiographers need to consider whether the change in
measurement is due to the reliability of the test or if a biological
change in the patient could explain the difference (e.g., worsening
of valve disease over the time period).DISCUSSION
To ensure that the methods we use in echocardiography are useful
for clinical decisions, reproducibility, repeatability, and reliability
should be assessed. Unreliable estimates have the potential to
impact patient management and outcomes, as well as leading to
a waste of time and resources. The challenge for the echocardiog-
rapher is not only to identify a change in a biologic parameter, but
then to know whether that change is real or clinically significant.
For example, is there a true change in cardiac structure and/or
function that would require additional treatment, or is the changeinconsistent or accounted for by changes to environment, operator,
or other factors?43
To identify any significant variability in echocardiographic
parameters within a department, intra- and interobserver variability
can be measured.9,44 The possibility of measurement error should
be minimized as much as possible by ensuring that all equipment
is accurately calibrated, adequate training is given to
echocardiographers, and standardized guidelines are followed.7 In
clinical practice, a patient being serially assessed will likely be scanned
by different echocardiographers on each occasion, hence the impor-
tance of ensuring no significant variation between operators. For
numeric data (such as LVEF or Doppler values), the degree of agree-
ment can be assessed using either the Bland-Altman plot or the ICC.
Pure measures of association (such as correlation and linear regres-
sion) provide limited information but are essential components of un-
derstanding and visualizing data to assess for outliers and points that
influence the trend of the data. When assessing a categorical result
(such as quantifying the severity of mitral regurgitation), a k test can
be used.7,9
Repeatability and reliability measurements are as important and
give confidence that the values obtained can be used to make clinical
decisions. Repeatability coefficients and the coefficient of variation are
commonly used and can be calculated without difficulty.7 For assess-
ment of within-subject variation, three repeat measurements are usu-
ally considered appropriate,7,45 translated into echocardiography as
the average of three Doppler indices. This is probably appropriate
for sinus rhythm, but in the case of atrial fibrillation, the assessment
of reproducibility is even more challenging because of the variation
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Figure 3 Cohen’s k to assess agreement of two observers for a graded result. Cohen’s k for the severity of mitral regurgitation in the
same patients by two echocardiographers. (A)Strong agreement demonstrated across all severity categories. (B)Minimal agreement
between the two echocardiographers. (C) Overall weak agreement between observers, with evidence of difference according to the
severity of mitral regurgitation. (D)Overall moderate agreement across all categories, despite complete agreement for the absence of
mitral regurgitation.
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atrial contraction and irregular ventricular contraction lead to beat-to-
beat changes in preload and hence variation in load-dependent echo-
cardiography variables.46 Although echocardiographers are recom-
mended to average multiple consecutive beats in patients with atrial
fibrillation, a systematic review by our group showed that isolating
and averaging beats with similar cardiac cycle length (the index beat
approach) could improve the overall reproducibility of measurement
in atrial fibrillation.47
Systematic assessment of reproducibility, repeatability, and reli-
ability is rare in routine clinical practice because of the existing de-
mands on clinical services, the extra time required, and the lack of
knowledge and tools to perform statistical evaluation. To facilitate
this process, we provide a simple online calculator that offers key sta-
tistical tests and can automatically create graphical plots by entering
echocardiographic data. The tool is available free of charge at www.
birmingham.ac.uk/echo. Users are encouraged to provide feedback
to improve this open-source tool and can elect to submit anonymous
data to help build up a picture of global echocardiographic reproduc-
ibility.
In contrast to clinical practice, there is already awareness in im-
aging research for the need to quantify intra- and interoperator
reproducibility, thereby providing some idea of generalizability to
routine care. Design of research studies that formally evaluate
reproducibility, repeatability, or reliability should clearly delineatewhat variation is specifically being assessed, with clear use of termi-
nology to avoid confusion. To accurately measure reproducibility,
these data should not be gathered as an accessory to other data
but with a distinct study plan. Similar to other study outcomes,
prior ascertainment of required sample size is vital so that a suffi-
cient number of observations are obtained for quantification
beyond the play of chance. Although outside the scope of this
report, resources are available to help plan appropriate study
size.48,49 Other important considerations are the method of
subject sampling and whether this is consecutive, random, or by
convenience (with implications on statistical method and potential
inclusion of bias), the degree of blinding possible, and appropriate
reporting of all facets of the study.50
Our discussion of reproducibility, repeatability, and reliability is
limited to common statistical tests that can easily be performed
in the clinical environment by echocardiographers without
much statistical knowledge. However, there are many other useful
statistical analyses that can be performed, and we would always
recommend working with a medical statistician to properly inter-
pret results. Quantifying these values in individuals, within echocar-
diography departments, and across different cardiac centers has the
potential to improve and enrich the clinical value of echocardiogra-
phy. In the future, artificial intelligence algorithms may be able to
automatically calculate and demonstrate the reproducibility of our
techniques, but for the foreseeable future, we still require human
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Figure 4 Repeatability and reliability assessment. Test-retest assessment for aortic valve peak velocity in the same patient with the
same operator. (A) Repeatable and reliable measurements, with low values for repeatability coefficient and coefficient of variation,
and small minimal detectable change. (B) Proportional bias with velocity increasing with more measurements taken, affecting
both repeatability and reliability. (C) Example of intermediate levels of repeatability and reliability. (D) Clear issue with repeatability
and reliability (possible equipment problem).
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December 2019effort to ensure the validity of physiological assessment through
echocardiography.
CONCLUSION
Echocardiography continues to grow in number, complexity, and clin-
ical importance. Ensuring reproducible, repeatable, and reliable mea-
surements is vital to base clinical decisions on echocardiographic
parameters. More frequent and better use of appropriate (and
straightforward) statistical tests has the potential to improve echocar-
diography at the level of individual echocardiographers and across im-
aging departments. An online tool for easy calculation of these
statistics in the clinical environment is available at www.
birmingham.ac.uk/echo.
ACKNOWLEDGMENT
We thank James Hodson (Institute of Clinical Sciences, University of
Birmingham, United Kingdom).REFERENCES
1. Steeds RP. Echocardiography: frontier imaging in cardiology. Br J Radiol
2011;84:S237-45.
2. Sonderegger-Iseli K, Burger S,Muntwyler J, Salomon F. Diagnostic errors in
three medical eras: a necropsy study. Lancet 2000;355:2027-31.3. Papolos A, Narula J, Bavishi C, Chaudhry FA, Sengupta PP. U.S. hospital
use of echocardiography: insights from the Nationwide Inpatient Sample.
J Am Coll Cardiol 2016;67:502-11.
4. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al.
Expert consensus for multimodality imaging evaluation of adult patients
during and after cancer therapy: a report from the American Society of
Echocardiography and the European Association of Cardiovascular Imag-
ing. Eur Heart J Cardiovasc Imaging 2014;15:1063-93.
5. Bartlett JW, Frost C. Reliability, repeatability and reproducibility: analysis
of measurement errors in continuous variables. Ultrasound Obstet Gyne-
col 2008;31:466-75.
6. Shammas HJ, Hoffer KJ. Repeatability and reproducibility of biometry and
keratometry measurements using a noncontact optical low-
coherence reflectometer and keratometer. Am J Ophthalmol 2012;153:
55-61.e2.
7. Watson PF, Petrie A.Method agreement analysis: a review of correct meth-
odology. Theriogenology 2010;73:1167-79.
8. Galderisi M, Henein MY, D’Hooge J, Sicari R, Badano LP, Zamorano JL,
et al. Recommendations of the European Association of Echocardiogra-
phy: how to use echo-Doppler in clinical trials: different modalities for
different purposes. Eur J Echocardiogr 2011;12:339-53.
9. Barnhart HX, Yow E, Crowley AL, Daubert MA, Rabineau D, Bigelow R,
et al. Choice of agreement indices for assessing and improving measure-
ment reproducibility in a core laboratory setting. Stat Methods Med Res
2016;25:2939-58.
10. Kengne C, Ouattara B, Angoran I, Anzouan C. Interobserver variability in
estimation of the left ventricular systolic function of dilated cardiopathies:
ejection fraction and global longitudinal strain. Arch Cardiovasc Dis 2018;
10:36.
Journal of the American Society of Echocardiography
Volume 32 Number 12
Bunting et al 151511. Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-
Mascherbauer R, et al. Quantitative assessment of left ventricular size
and function: side-by-side comparison of real-time three-dimensional
echocardiography and computed tomography with magnetic resonance
reference. Circulation 2006;114:654-61.
12. Palmieri V, Dahlof B, DeQuattro V, SharpeN, Bella JN, de Simone G, et al.
Reliability of echocardiographic assessment of left ventricular structure
and function: the PRESERVE study. Prospective Randomized Study Eval-
uating Regression of Ventricular Enlargement. J AmColl Cardiol 1999;34:
1625-32.
13. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovic ZB,
Marwick TH. Reproducibility of echocardiographic techniques for sequen-
tial assessment of left ventricular ejection fraction and volumes: applica-
tion to patients undergoing cancer chemotherapy. J Am Coll Cardiol
2013;61:77-84.
14. Hensel KO, Roskopf M, Wilke L, Heusch A. Intraobserver and interob-
server reproducibility of M-mode and B-mode acquired mitral annular
plane systolic excursion (MAPSE) and its dependency on echocardio-
graphic image quality in children. PLoS ONE 2018;13:e0196614.
15. King A, Thambyrajah J, Leng E, Stewart MJ. Global longitudinal strain: a
useful everyday measurement? Echo Res Pract 2016;3:85-93.
16. Armstrong AC, Gjesdal O, Almeida A, Nacif M, Wu C, Bluemke DA, et al.
Left ventricular mass and hypertrophy by echocardiography and cardiac
magnetic resonance: the multi-ethnic study of atherosclerosis. Echocardi-
ography 2014;31:12-20.
17. LaBounty TM, Sundaram B, Agarwal P, Armstrong WA, Kazerooni EA,
Yamada E. Aortic valve area on 64-MDCT correlates with transesophageal
echocardiography in aortic stenosis. AJR Am J Roentgenol 2008;191:
1652-8.
18. Mavrides E, Holden D, Bland JM, Tekay A, Thilaganathan B. Intraobserver
and interobserver variability of transabdominal Doppler velocimetry mea-
surements of the fetal ductus venosus between 10 and 14 weeks of gesta-
tion. Ultrasound Obstet Gynecol 2001;17:306-10.
19. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al.
Comparison of interstudy reproducibility of cardiovascular magnetic reso-
nance with two-dimensional echocardiography in normal subjects and in
patients with heart failure or left ventricular hypertrophy. Am J Cardiol
2002;90:29-34.
20. Selamet Tierney ES, Levine JC, Chen S, Bradley TJ, Pearson GD,
Colan SD, et al. Echocardiographic methods, quality review, andmeasure-
ment accuracy in a randomized multicenter clinical trial of Marfan syn-
drome. J Am Soc Echocardiogr 2013;26:657-66.
21. Lin LI. A concordance correlation coefficient to evaluate reproducibility.
Biometrics 1989;45:255-68.
22. Bland. An introduction to medical statistics. Oxford, UK: Oxford Univer-
sity Press; 2015.
23. Liao JJ, Capen RC, Schofield TL. Assessing the reproducibility of an analyt-
ical method. J Chromatogr Sci 2006;44:119-22.
24. Hallgren KA. Computing inter-rater reliability for observational data: an
overview and tutorial. Tutor Quant Methods Psychol 2012;8:23-34.
25. Bland JM, Altman DG. Statistical methods for assessing agreement be-
tween two methods of clinical measurement. Lancet 1986;1:307-10.
26. Motulsky H, Christopoulos A. Fitting models to biological data and linear
and nonlinear regression. New York: Oxford University Press; 2004.
27. Popovic ZB, Thomas JD. Assessing observer variability: a user’s guide. Car-
diovasc Diagn Ther 2017;7:317-24.
28. van Stralen KJ, Jager KJ, Zoccali C, Dekker FW. Agreement between
methods. Kidney Int 2008;74:1116-20.
29. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability.
Psychol Bull 1979;86:420-8.
30. Vaz S, Falkmer T, Passmore AE, Parsons R, Andreou P. The case for using
the repeatability coefficient when calculating test-retest reliability. PLoS
ONE 2013;8:e73990.31. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating
normed and standardized assessment instruments in psychology. Psychol
Assess 1994;6:284-90.
32. Koo TK, Li MY. A Guideline of selecting and reporting intraclass cor-
relation coefficients for reliability research. J Chiropr Med 2016;15:
155-63.
33. Hedberg EC, Ayers S. The power of a paired t-test with a covariate. Soc Sci
Res 2015;50:277-91.
34. Ludbrook J. Linear regression analysis for comparing two measurers or
methods of measurement: but which regression? Clin Exp Pharmacol
Physiol 2010;37:692-9.
35. Giavarina D. Understanding Bland Altman analysis. Biochemia Medica
2015;25:141-51.
36. Gwet KL. Testing the difference of correlated agreement coefficients for
statistical significance. Educ Psychol Meas 2016;76:609-37.
37. Esquitin KA, Khalique OK, Liu Q, Kodali SK, Marcoff L, Nazif TM, et al.
Accuracy of the single cycle length method for calculation of aortic effec-
tive orifice area in irregular heart rhythms. J Am Soc Echocardiogr 2019;
32:344-50.
38. Naylor JM, Hayen A, Davidson E, Hackett D, Harris IA, Kamalasena G,
et al. Minimal detectable change for mobility and patient-reported tools
in people with osteoarthritis awaiting arthroplasty. BMC Musculoskelet
Disord 2014;15:235.
39. Powden CJ, Hoch JM, Hoch MC. Reliability and minimal detectable
change of the weight-bearing lunge test: a systematic review. Man Ther
2015;20:524-32.
40. Albert A, Zhang L. A novel definition of the multivariate coefficient of
variation. Biom J 2010;52:667-75.
41. Vickers AJ. The use of percentage change from baseline as an outcome in a
controlled trial is statistically inefficient: a simulation study. BMCMed Res
Methodol 2001;1:6.
42. Kim S, Kim H. A new metric of absolute percentage error for intermittent
demand forecasts. Int J Forecast 2016;32:669-79.
43. Rijsterborgh H, Mayala A, Forster T, Vletter W, van der Borden B,
Sutherland GR, et al. The reproducibility of continuous wave
Doppler measurements in the assessment of mitral stenosis or mitral
prosthetic function: the relative contributions of heart rate, respira-
tion, observer variability and their clinical relevance. Eur Heart J
1990;11:592-600.
44. Douglas PS, DeCara JM, Devereux RB, Duckworth S, Gardin JM,
Jaber WA, et al. Echocardiographic imaging in clinical trials: American So-
ciety of Echocardiography Standards for echocardiography core labora-
tories: endorsed by the American College of Cardiology Foundation. J
Am Soc Echocardiogr 2009;22:755-65.
45. Frikha Z, GirerdN, HuttinO, Courand PY, Bozec E, Olivier A, et al. Repro-
ducibility in echocardiographic assessment of diastolic function in a pop-
ulation based study (the STANISLAS Cohort study). PLoS ONE 2015;
10:e0122336.
46. Muntinga H, Gosselink A, Blanksma P, De Kam PJ, Wall E, Crijns H. Left
ventricular beat to beat performance in atrial fibrillation: dependence on
contractility, preload, and afterload. Heart 1999;82:575-80.
47. Kotecha D, Mohamed M, Shantsila E, Popescu BA, Steeds RP. Is echocar-
diography valid and reproducible in patients with atrial fibrillation? A sys-
tematic review. Europace 2017;19:1427-38.
48. Walter SD, EliasziwM, Donner A. Sample size and optimal designs for reli-
ability studies. Stat Med 1998;17:101-10.
49. Giraudeau B, Mary JY. Planning a reproducibility study: how many sub-
jects and how many replicates per subject for an expected width of the
95 per cent confidence interval of the intraclass correlation coefficient.
Stat Med 2001;20:3205-14.
50. Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hrobjartsson A,
et al. Guidelines for reporting reliability and agreement studies (GRRAS)
were proposed. J Clin Epidemiol 2011;64:96-106.
